CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis
Amount Raised
$12 Million
Round Type
series a
Description
CloudCath, a company dedicated to remote complication monitoring for patients undergoing catheter-based treatments, today announced that it has completed a $12 million Series A financing led by Capital Integral with participation from FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund, and additional strategic and individual investors. Proceeds from the round will be used to commercialize CloudCath’s first product, a system that enables remote, real-time monitoring for patients undergoing at-home peritoneal dialysis, allowing earlier complication intervention. Funding will also support the development of additional applications utilizing the company’s proprietary technology.
FundzWatch™ Score
Buyer Intent Analysis
Get personalized insights on buying likelihood